Stocks · News reference

PDS Biotech shares are trading higher. The company announced initial closing of up to $22.3 million PIPE financing.

Sep 14, 2026, 7:12 PMBenzinga Newsdesk

Reference Details

Connected Markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

Keep reading

BenzingaSep 22, 2026, 12:08 PMBenzinga Newsdesk
PDS Biotechnology Announces Publication Of Results From Phase 2 Trial Evaluating PDS0101, HPV16-Targeted Immunotherapy, In Combination With Pembrolizumab In JAMA Oncology, Peer Reviewed Journal Of American Medical Association
39.3 months median overall survival in first-line (1L) R/M immune checkpoint inhibitor naïve patientsCompany continues to prioritize PDS0301 in metastatic colorectal cancer (mCRC) while pursuing partnership strategy for
PDSB
SEC EDGARSep 22, 2026, 12:05 PMSEC EDGAR
8-K filing — PDS Biotechnology Corp (PDSB)
Filed: 2026-09-22 AccNo: 0001140361-26-037298 Size: 173 KB Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits
PDSB
BenzingaSep 15, 2026, 6:12 PMHenry Khederian
PDS Biotech Stock Surges Tuesday: What's Driving the Action?
Shares of PDS Biotechnology Corp (NASDAQ: PDSB) are trading sharply higher Tuesday afternoon, extending Monday's gains as investors continue to react to the closing of a multi-tranche financing agreement.
PDSB